Atommap announced it raised $7.08 Million in an initial filing from an offering of $7.08 Million
Nov 16, 2023•almost 2 years ago
Amount Raised
$7.08 Million
New YorkBiotechnology
Company Information
Company
Atommap
Location
1059 3RD AVENUE
New York, New York, United States
About
Atommap's physics-based and ML-augmented computational drug discovery platform has powered Silicon Therapeutics and Roivant Discovery to deliver a clinical stage STING agonist, potent inhibitors against a high-valued but challenging oncology target, and active molecules for therapeutic degradation of target proteins.